|
Pharmaceutical Intermediates |
|
We are producing following pharmaceutical intermediates:
Amlodipine Besylate
-
Hydroxy Ethyl Phthalamide.
-
Methyl-3- Amino- Crotonate / [14205-34-1] 3-amino crotonic acid methyl ester
-
2-[(2-phthaloylethoxy)methyl]-4-(2-chlorophenyl)- 3-ethoxycarbonyl-5-methoxy-carbonyl-6-methyl- 1,4-dihydropyridine
-
2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)- [88150-42-9] 3-ethoxycarbonyl-5-methoxy-carbonyl-6-methyl-1, 4-dihydropyridine
Carvedilol
-
2-(2-Methoxyphenoxy) ethylamine Hydrochloride [64464-07-9]
-
2-(2-Methoxyphenoxy)ethyl amine
-
1,2,3,4-Tetrahydro-4-oxocarbazole [2295-31-0]
-
4-hydroxy-9-(H)-Carbazol [54989-33-2]
-
4-Oxiranylmethoxy-9(H)Carbazol [51997-51-4]
Ethambutol Hydrochloride
Fluoxetine Hydrochloride
Glibenclamide
Lacidipine
Loratadine
-
2-Cyano-3[2(3-Chlorophenyl)ethyl]Pyridine / 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarbonitrile
-
(1-Methyl-4-piperidinyl)-[3-[2-(3Chlorophenyl)ethyl]- 2-pyridinyl]-methanone hydrochloride.
-
8-Chloro-10,11dihydro-4-aza-5H-dibenzo- [31521-41-9] (a,d)cycloheptan-5-one
Olanzapine
-
2-Amino-3-Cyano-5-Methyl-Thiophene
-
2-Methyl-4-Amino-10H-thieno (2,3-b)(1,5)-benzodiazepine
Ondansetron Hydrochloride
-
1,2,3,9- Tetrahydro-4 H- Carbazol-4-one. [15128-52-6]
-
9-methyl-1,2,3,9-Tetrahydro-4H-carbazole-4-one. [27387-31-1]
Pioglitazone Hydrochloride
-
2-(5-Ethyl-2-Pyridyl) ethanol/5-Ethyl-Pyridine-2-Ethanol [5223-06-3]
-
2,4- Thiazolidinedione [2295-31-0]
-
5-[[4-[2-(5ethyl-2-pyridinyl)ethoxy]phenyl]methylene]-2, [144809-28-9] 4-Thiazolidinedione /5[4-2(5-ethyl-2-pyridinyl)ethoxy] benzylidiene-2,4-Thiazolidinedione
Rabeprazole Sodium
Venlafaxine Hydrochloride
-
1-[Cyano-(p-Methoxyphenyl)methyl]Cyclohexanol
-
1-[2-amino-1-(p-methoxyphenyl)ethyl]cyclohexanol acetate.
-
1-[2-amino-1-(p-methoxyphenyl)ethyl]cyclohexanol [130198-05-9] hydrochloride.
|
We Also Offer Intermediates For :
|
- Cilostazol
- Nebivolol
- Zolpidem Tartrate
|
|
-
Products covered by valid patents are not offered or supplied for commercial use.
-
The customer should verify the patents Position.
-
Products Currently covered by valid US patents are offered for R&D use in accordance with 35 USC 2718(e) + A13(1).
|